Jerry Lynn Pommer's most recent trade in SAB Biotherapeutics Inc was a trade of 69,793 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 22, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics Inc | Jerry Lynn Pommer | Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 69,793 | 69,793 | - | - | Employee Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | Jerry Lynn Pommer | Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 36,890 | 36,890 | - | - | Earnout Rights (Restricted Stock Units) | |
| SAB Biotherapeutics Inc | Jerry Lynn Pommer | Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 14,540 | 14,540 | - | - | Employee Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | Jerry Lynn Pommer | Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 6,979 | 6,979 | - | - | Employee Stock Option (right to buy) |